KRT18 and cancer: A two-step procedure, combining sorting out all leukocytes (CD45+) and searching for cells positive for common epitopes of cytokeratins (CK8, CK18 and CK19) and CD44, demonstrated that it was not the presence of cancer cells, but their phenotype that determined patients’ prognosis.